Elekta and Philips have recently announced that the Froedtert & Medical College of Wisconsin Clinical Cancer Center in Milwaukee, WI, USA will join their consortium which is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.
“The Froedtert & Medical College of Wisconsin Clinical Cancer Center is an exceptional addition to the consortium,” says Tomas Puusepp, Elekta President and CEO. “It is a nationally renowned cancer research institute, boasts in-depth expertise in every kind of cancer, is staffed by fully coordinated specialist teams and uses the latest innovative therapies and technologies.”
The Froedtert & Medical College of Wisconsin Clinical Cancer Center is the fifth member to sign the research agreement to evaluate the new technology, which unites radiation therapy and MRI in a single system. Current clinical members of the group include the University Medical Center Utrecht (Utrecht, the Netherlands); The University of Texas MD Anderson Cancer Center (Houston, Texas, USA); The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands) and Sunnybrook Health Sciences Centre (Toronto, Ontario, Canada).
In the consortium, Philips and Elekta are seeking to merge advanced MRI systems with precision radiation therapy in a single MRI-guided radiation therapy system. This will enable clinicians to achieve exceptional soft tissue imaging during radiation therapy and to adapt treatment delivery in real-time for extremely precise cancer treatments.
Integrating an advanced 1.5 Tesla MRI machine with a sophisticated adaptive radiation therapy system will provide physicians with depictions of a patient’s soft tissues and tumor and allow them to dynamically track their motion. Elekta will seek to merge advanced MRI with precision radiation therapy in a single MRI-guided radiation therapy system. This will enable doctors to achieve exceptional soft tissue imaging during radiation therapy and to adapt treatment delivery in real-time for extremely precise cancer treatments.
Integrating an advanced 1.5 Tesla MRI machine with a sophisticated adaptive radiation therapy system will provide physicians with depictions of patient’s soft tissues and tumors and allow them to dynamically track their motion. This innovation is designed to enable clinicians to deliver radiation under real-time MR guidance.
Elekta